About
Welcome to the Meshinchi Lab at Fred Hutch
Our research laboratory is studying genomic expression of acute myeloid leukemia-restricted targets on the cell surface that are ideal for immunotherapeutic targeting with chimeric antigen receptor T-cell (CAR T) therapies, as well as identifying and validating target genes for further immunotherapy development.
Currently, Soheil Meshinchi, M.D., Ph.D., working in collaboration with Franco Locatelli, M.D., Ph.D. and Concetta Quintarelli, M.D., Ph.D. at the Bambino Gesù Children’s Hospital IRCCS in Rome, Italy, we are investigating the potential of CAR T-cell therapy in pediatric acute myeloid leukemia (AML) and T-Cell Acute Lymphoblastic Leukemia (T-ALL) patients.
The Meshinchi and Locatelli Lab Group documentation for creating, maintaining, and contributing to the Meshinchi and Locatelli Lab’s software and data analysis pipelines on github.
Contact
Fred Hutch
Soheil Meshinchi
Rhonda Ries
OPBG
Franco Locatelli
Concetta Quintarelli